Australia, Oct. 21 -- Soleno Therapeutics Inc., owns the trademark (2574717) for 'VYKAT' till April 25, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations to treat Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia; pharmaceutical preparations for the treatment of orphan diseases.]
Type of Mark: Word
Date of Acceptance: Aug. 11
Registration Advertised: Oct. 20
For further details contact John Paul Oleksiuk Cooley LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2574717.
Disclaimer: Curated by HT Syndication.
